Background

Education

• Lehigh University, B.S., Biochemistry, 2001

  Brown University, Ph.D., Molecular Biology, Cell Biology, and Biochemistry, 2007

  Suffolk University Law School, J.D., Candidate, 2013

Professional Involvement

• American Association for the Advancement of Science (AAAS)
• Women’s Bar Association

Honors & Awards

• The Kirschstein National Research Service Award from the National Institutes of Health

Practice Areas

Life Sciences, Patents

Industry & Technical Focus

Biotechnology, Chemistry, Pharmaceuticals, Molecular Biology, Cell Biology, Oncology, Proteomics

Practice Description

Dr. Lawson assists clients with the strategic development, protection, and management of biotechnology patent portfolios.

Notable Experience

• Assisting with the drafting and prosecuting of U.S. and foreign patent applications.
• Conducting freedom to operate analyses and drafting infringement and invalidity opinions.
• Conducted graduate work in the Division of Biology and Medicine at Brown University. Her research focused on the role of the cell-cell adhesion molecule CEACAM1 in hepatocellular carcinoma.
• Extensive research in the field of proteomics and techniques, including 2DE, Blue Native-PAGE, SELDI-TOF MS, LC/MS/MS.

Publications & Speaking Engagements

• Co-author, “District Court Invalidates Gene Patents,” June 2010.
• Speaker, “A Novel Model System for Analyzing the Functional Domains of Ceacam1a-4S,” Experimental Biology, Washington D.C. April 28-May 2, 2007. (abstract number 372.4)
• Poster Presentation, “Use of Magnetic Beads with Immobilized Monoclonal Antibodies for Isolation of Highly Pure Plasma Membranes,”  Stem Cell and Cancer Therapeutics Symposium, Providence, RI, May 24, 2006.
• Poster Presentation, “A Novel Model System for Analyzing the Signaling Pathways of Ceacam1-4S,” The Proteome Society: Boston Chapter, Boston, MA, October 19, 2005.
• Speaker, “A Novel Model System for Analyzing the Signaling Pathways of Ceacam1-4S,” Rhode Island Hospital – 13th Annual Hospital Research Celebration. Providence, RI, September 29, 2005.
• Speaker, “A Novel Model System for Analyzing the Signaling Pathways of Ceacam1-4S,” 15th Annual International CEA Symposium,  Berlin / Potsdam-Babelsberg, Germany, July 21-24, 2005.
• Poster Presentation, “The Effects of Ceacam1b-4S on Tumorigenicity, AASLD,” American Association for the study of Liver Diseases, Boston, MA, October 24- 28, 2003. (Hepatology. Vol 38, No.4, Suppl.1, 574A 858)
• Author, works published in the journal Electrophoresis.